Anzeige
Mehr »
Freitag, 27.06.2025 - Börsentäglich über 12.000 News
Blockbuster-Bohrergebnisse: Gold-Antimon-Fund in Nevada trifft geopolitischen Nerv
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2N7AA | ISIN: CA58504D1006 | Ticker-Symbol: MLZ
Tradegate
26.06.25 | 15:09
0,050 Euro
+7,73 % +0,004
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
MEDIPHARM LABS CORP Chart 1 Jahr
5-Tage-Chart
MEDIPHARM LABS CORP 5-Tage-Chart
RealtimeGeldBriefZeit
0,0430,05317:06
0,0450,05116:42

Aktuelle News zur MEDIPHARM LABS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MEDIPHARM LABS Aktie jetzt für 0€ handeln
19.06.Aurora Cannabis Inc (3): Aurora Cannabis denies MediPharm partnership rumour40
17.06.Medipharm Labs Corp: Medipharm Labs shareholders approve all matters at ASM7
17.06.MediPharm Labs Corp.: MediPharm Announces Voting Results from the 2025 Annual and Special Meeting of Shareholders520TORONTO, June 17, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids...
► Artikel lesen
16.06.Medipharm Labs Corp: Medipharm cautions holders re annual meeting results7
16.06.MediPharm Labs Corp.: MediPharm Cautions Shareholders To Await Final Results of Annual and Special Meeting4
16.06.Apollo Technology Capital Corporation: Apollo Capital Wins Proxy Contest at MediPharm Labs212MediPharm Labs' Board's Material and Unprecedented Breaches of Securities Laws Are Part of Their Undoing Apollo Capital's Entire Slate of Board Nominees Constitute the New Board of Directors for MediPharm...
► Artikel lesen
13.06.Medipharm Labs Corp: Medipharm garners Glass Lewis rec for director nominees4
13.06.MediPharm Labs Corp.: Leading Independent Proxy Advisor Glass Lewis Recommends Shareholders Vote the GREEN proxy FOR ALL MediPharm Director Nominees4
12.06.Medipharm Labs Corp: Medipharm reminds investors of June 13 voting deadline1
12.06.Medipharm Labs Corp: Medipharm dissident Apollo court case dismissed13
12.06.MediPharm Labs Corp.: MediPharm Reminds Shareholders to Vote in Advance of June 13 Deadline3
11.06.MediPharm Labs Corp.: MediPharm Announces Complete Dismissal of Dissident Court Proceeding Related to Annual and Special Meeting148TORONTO, June 11, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids...
► Artikel lesen
11.06.Medipharm Labs Corp: Medipharm dissident Apollo urges vote with gold card1
11.06.Schreiner MediPharm Introduces Smart Syringe Box1
11.06.Apollo Capital seeks board changes at MediPharm Labs3
11.06.Apollo Kapital fordert Vorstandsänderungen bei MediPharm Labs1
11.06.Apollo Technology Capital Corporation: Apollo Capital Releases Investor Presentation Highlighting Plan to Make MediPharm Labs the World's Leading International Medical Cannabis Company2
11.06.Digitale Trackinglösung von Schreiner MediPharm optimiert klinische Studien: Die neue Smart Syringe ...2
10.06.Medipharm Labs Corp: Medipharm founder, ex-CEO McCutcheon joins dissident7
10.06.Apollo Technology Capital Corporation: MediPharm Labs' Founder-CEO Pat McCutcheon Throws his Support behind Apollo Capital as Dissident188McCutcheon Agrees with Apollo that Urgent Change is Needed, including Complete Turnover at the Board Level after Years of Value-Destruction Apollo Capital Announces Filing of Circular Addendum to...
► Artikel lesen
Weiter >>
82 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1